HOME >> BIOLOGY >> NEWS
APS Inflammatory Bowel Diseases Translational Research Conference, Sept. 8-11

Bethesda, MD (June 22, 2004) The American Physiological Society (APS) announces it is sponsoring a translational research conference entitled "Immunological and Pathophysiological Mechanisms in Inflammatory Bowel Diseases" from Sept. 8-11, 2004 in Snowmass, Colorado.

The keynote lecture, "IBD: Light at the End of the Tunnel?" will be delivered by Daniel Podolsky, M.D., professor of medicine at Harvard Medical School and chief of the gastrointestinal unit at the affiliated Massachusetts General Hospital.

The final panel of the meeting, featuring researchers from the Mayo Clinic, Cedars-Sinai Medical Center, University of Barcelona, Spain, and University of Bologna, Italy, will describe new therapeutic strategies in the treatment of IBD.

In addition to evening sessions involving research poster presentations, the meeting will feature symposia led by noted researchers on the following subjects:

  • Genetics of IBD
  • Role of the immune system in intestinal inflammation: Who are the players and what do they do?
  • Innate immune responses in IBD: Role of the vasculature
  • Cytokines, chemokines and mediators of chronic inflammation
  • Bacterial/host interactions in the pathogenesis of IBD
  • New therapeutic strategies in the treatment of IBD

According to co-organizers Matthew Grisham, of Louisiana State University, Shreveport and Fabio Cominelli, of the University of Virginia, the IBD conference is the "first in a series of translational, that is, bench to bedside, conferences to be sponsored by APS aimed at bringing together internationally recognized scientists and clinicians as well as promising young investigators" in a variety of physiological subjects.

Speakers and other participants, many of whom will be presenting poster abstracts, come from all over world, and include researchers and students from the graduate through senior research/faculty level.

Abstra
'"/>


Contact: Mayer Resnick
mresnick@the-aps.org
301-634-7209

Stacy Brooks
sbrooks@the-aps.org
301-634-7253

American Physiological Society
22-Jun-2004


Page: 1 2 3

Related biology news :

1. New Gene Holds Promise For Controlling Crohns And Other Inflammatory Diseases
2. University Of Chicago, Hopkins Narrow Search For Inflammatory Bowel Disease Genes: New Study Provides Evidence For Important Gene-Gene Interaction
3. Naturally Produced Enzyme May Be Useful In Inflammatory Arthritis
4. Omaha to host International Small Bowel Transplant Symposium
5. Doctors Find Lead On Common Genes Which Can Lead To Bowel Cancer
6. International Conference on Emerging Infectious Diseases
7. NIH establishes Rare Diseases Clinical Research Network
8. 2002 International Conference on Emerging Infectious Diseases
9. HHMI To Award $14 Million In New International Program To Support Research On Infectious And Parasitic Diseases
10. Sandia Discovery About Protein May Help Clean Up Pollutants, Find Cures For Diseases
11. Autoimmune Diseases May Be Triggered By Cells From Your Mother

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... , ... November 12, 2019 ... ... a global leader in the design and manufacturer of technical ergonomic seating ... and adjustable footrests compliant with Healthier Hospital Initiative guidelines. Established by Practice ...
(Date:11/9/2019)... ... November 08, 2019 , ... SiteSeer Technologies, creator of SiteSeer Professional retail site ... and user of SiteSeer. The boutique real estate developer of single and multi-tenant buildings ... to supplement its own analysis of markets. , Geoffrey Kerth, manager of GPK ...
(Date:11/6/2019)... ... November 06, 2019 , ... Genomenon® ... Engine now includes the ability to search the entirety of the genomic literature ... genetic and rare diseases. , Patients, particularly those with rare diseases, don’t always ...
Breaking Biology News(10 mins):
(Date:10/26/2019)... ... October 24, 2019 , ... Sparks Marketing ... Group (BMMG), a boutique healthcare-specific marketing firm, to strengthen the agency’s growing ... Strategy Division. , Healthcare clients in pharma, bio-therapeutics, medical device and healthcare technologies ...
(Date:10/22/2019)... ... October 22, 2019 , ... ... announced that its lead program, DBI-001, met its primary safety endpoints, with no ... phase 2a clinical trial for the treatment of interdigital tinea pedis (athlete’s foot). ...
(Date:10/10/2019)... ... 09, 2019 , ... The International Society for Pharmaceutical ... a newly-confirmed keynote speaker for the 2019 ISPE Annual Meeting & Expo ... Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized clinical data ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Suresh and Leslie Maurer presented company executives with a set of recommendations to ... graduates will offer insights from their TMP to a wider audience of industry ...
Breaking Biology Technology:
Cached News: